1. Home
  2. DRMA vs MITQ Comparison

DRMA vs MITQ Comparison

Compare DRMA & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.26

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Moving iMage Technologies Inc.

MITQ

Moving iMage Technologies Inc.

HOLD

Current Price

$0.61

Market Cap

5.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRMA
MITQ
Founded
2014
N/A
Country
United States
United States
Employees
9
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
DRMA
MITQ
Price
$1.26
$0.61
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
1.8M
18.6K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
N/A
$20,139,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$60.36
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.42
52 Week High
$7.33
$1.66

Technical Indicators

Market Signals
Indicator
DRMA
MITQ
Relative Strength Index (RSI) 46.30 45.25
Support Level $1.13 $0.50
Resistance Level $1.84 $0.64
Average True Range (ATR) 0.16 0.05
MACD 0.01 0.01
Stochastic Oscillator 22.30 40.20

Price Performance

Historical Comparison
DRMA
MITQ

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: